Article · 29 Aug 2026
Conference abstract
Therapeutic vaccines using immune regulatory functions of invariant natural killer T (iNKT) cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Invariant natural killer T (iNKT) cells having Th e invariant T cell antigen receptor (TCR) chain are a unique population to regulate the immune response between the innate and acquired immunity. iNKT cells interact with glycolipids presented via CD1d molecule on antigen-presenting cells (APCs), resulting in the activation of killing activity and the production of a variety of cytokines. KRN7000, alpha-galacosyl ceramide ( -GalCer), among glycolipids functions as the powerful ligand for not only rodent but also primate iNKT cells. As iNKT cells potentially have two bi-directional functions, one is immune activation and the other is immune suppression, it was expected that KRN7000 would be utilized as an adjuvant for various vaccines of cancer, infectious and immune diseases. However, the pharmaceutical development of KRN7000 is not successful because of the bi-directional functions of iNKT cells. In our recent studies, two functions of immune activation and suppression are dissected by the in vivo delivery system of KRN7000. Dendritic cells (DCs), the professional APCs, could be used as delivery cells of KRN7000 for immune activa tion. Systemic administration of KRN7000-pulsed DCs preferentially enhanced protective immunity against tumors and infection by microbes. In contrast, liposomal formulation of KRN7000 could be delivered to the marginal zone B220- positive cells in a spleen, induce regulatory T cells (Treg) and diminish immune responses in model animals of autoimmunity, allergic diseases and graft versus host diseases (GvHD)
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Yasuyuki Ishi”